<main role="main" class="detailed-guide" lang="en">
      


<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

<div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>

  
  <h1 class="gem-c-title__text govuk-heading-l">
    Monitoring reports of the effectiveness of COVID-19 vaccination
  </h1>
</div>
  </div>
  
  <div class="govuk-grid-column-two-thirds">
      
  <p class="gem-c-lead-paragraph">Data on the real-world efficacy of the COVID-19 vaccines.</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
      <div class="gem-c-metadata" data-module="gem-toggle">
  <dl data-module="gem-track-click">
      <dt class="gem-c-metadata__term">From:</dt>
      <dd class="gem-c-metadata__definition">
          <a href="/government/organisations/uk-health-security-agency" class="govuk-link">UK Health Security Agency</a>

      </dd>
      <dt class="gem-c-metadata__term">Published</dt>
      <dd class="gem-c-metadata__definition">15 November 2021</dd>
      <dt class="gem-c-metadata__term">Last updated</dt>
      <dd class="gem-c-metadata__definition">
        16 December 2021
          — <a href="#history" data-track-action="see-all-updates-link-clicked" data-track-label="history" class="gem-c-metadata__definition-link govuk-!-display-none-print" data-track-category="content-history">
            See all updates
          </a>
      </dd>
  </dl>
</div>
    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>







<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    
  <section class="gem-c-devolved-nations">
    <h2 class="govuk-heading-s govuk-!-margin-bottom-0">
      Applies to England
</h2>
</section>

      <div class="app-c-contents-list-with-body">
    
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>

        
<div data-module="govspeak" class="gem-c-govspeak govuk-govspeak ">
    
          <div class="govspeak">
<p>The Health Security Agency (UKHSA) is monitoring the effectiveness of the coronavirus (COVID-19) vaccines in the real world as set out in the <a class="govuk-link" href="https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-strategy">COVID-19 vaccine surveillance strategy</a> and has published reports on the impact of the COVID-19 vaccines on:</p>

<ul>
  <li>symptomatic disease</li>
  <li>hospitalisation</li>
  <li>death</li>
  <li>infection (symptomatic or asymptomatic)</li>
</ul>

<h4>Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against COVID-19 related symptoms and hospitalisation in England: test negative case-control study</h4>
<p>This study provides real world evidence of significant <a class="govuk-link" href="https://khub.net/documents/135939561/338928724/Effectiveness+of+BNT162b2+COVID-19+booster+vaccine.pdf/330374ad-970c-42bb-8461-7c1ec57c403b?t=1639651397520" rel="external">increased protection from the booster vaccine dose against symptomatic disease and hospitalisation</a> irrespective of the primary course.</p>

<h4>Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern</h4>
<p>This study reports on the <a href="https://www.medrxiv.org/content/10.1101/2021.12.14.21267615v1" class="govuk-link" rel="external">vaccine effectiveness against symptomatic disease</a> with 2 dose courses of BNT1622 and ChAdOx1-S as well as booster doses of BNT162b2 following a primary course of either BNT1622 or ChAdOx1-S.</p>

<h4>Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against COVID-19 related symptoms in England: test negative case-control study</h4>
<p>Results from the <a href="https://www.medrxiv.org/content/10.1101/2021.11.15.21266341v1" rel="external" class="govuk-link">first UK real-world study</a> by UKHSA show significantly increased protection against symptomatic disease from a booster dose of the Pfizer-BioNTech vaccine in those aged 50 years and older.</p>

<h4>Vaccine effectiveness and duration of protection</h4>
<p>This study reports on the <a href="https://www.medrxiv.org/content/10.1101/2021.09.15.21263583v1" class="govuk-link" rel="external">vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax</a> against mild and severe COVID-19 in the UK.</p>

<h4>Different dosing schedules and vaccine effectiveness</h4>
<p>This <a rel="external" href="https://www.medrxiv.org/content/10.1101/2021.07.26.21261140v1.full" class="govuk-link">study investigates</a> the impact of different dosing schedules on immune response and vaccine effectiveness.</p>

<h4>Vaccine effectiveness in clinical risk groups</h4>
<p>This study reports on the <a href="https://khub.net/documents/135939561/430986542/RCGP+VE+riskgroups+paper.pdf/a6b54cd9-419d-9b63-e2bf-5dc796f5a91f" class="govuk-link" rel="external">immune response and clinical effectiveness</a> of COVID-19 vaccine among individuals in clinical risk groups. A <a rel="external" href="https://khub.net/documents/135939561/430986542/RCGP+VE+serology+supplementary+material.pdf/f5e65a07-2683-9bbb-a99f-b8c10d7c835d" class="govuk-link">supplementary appendix</a> is also available to download.</p>

<h4>Vaccine effectiveness with Delta variant on hospitalisation</h4>
<p>This study reports on the <a href="https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view/479607266" rel="external" class="govuk-link">effectiveness of COVID-19 vaccines on hospitalisation disease with the Delta variant</a>. A supplementary appendix is also available to download.</p>

<h4>Vaccine effectiveness with Delta variant on symptomatic disease</h4>
<p>This study reports on the <a rel="external" class="govuk-link" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2108891">effectiveness of COVID-19 vaccines on symptomatic disease</a> with the Delta variant.</p>

<h4>Effectiveness of COVID-19 vaccines against hospitalisation</h4>
<p>A <a href="https://khub.net/documents/135939561/430986542/Effectiveness+of+BNT162b2+mRNA+and+ChAdOx1+adenovirus+vector+COVID-19+vaccines+on+risk+of+hospitalisation+among+older+adults+in+England.pdf/9e18c525-dde6-5ee4-1537-91427798686b" rel="external" class="govuk-link">study using the SARI watch surveillance system of COVID-19 hospitalisations</a> found high levels of protection against hospitalisation after both a single dose and 2 doses of COVID-19 vaccines.</p>

<h4>Effectiveness of COVID-19 vaccines on mortality</h4>
<p>A <a class="govuk-link" rel="external" href="https://www.medrxiv.org/content/10.1101/2021.05.14.21257218v1">study on deaths with COVID-19</a> indicates that COVID-19 vaccines offer high levels of protection against mortality.</p>

<h4>Impact on household transmission</h4>
<p><a rel="external" href="https://www.nejm.org/doi/full/10.1056/NEJMc2107717" class="govuk-link">Impact of vaccination on household transmission of SARS-COV-2 in England</a> is an analysis to determine whether individuals who have received vaccine, but still become infected with SARS-COV-2 up to 60 days after the first dose, are less likely than unvaccinated cases to transmit to their unvaccinated household contacts.</p>

<h4>VIVALDI study</h4>
<p>The <a rel="external" class="govuk-link" href="https://www.medrxiv.org/content/10.1101/2021.03.26.21254391v1">VIVALDI study</a> found evidence that COVID-19 vaccines were associated with a substantially reduced risk of infection in care home residents.</p>

<h4>Avon CAP study</h4>
<p>The <a rel="external" href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3796835" class="govuk-link">Avon CAP study</a>, conducted in 2 hospitals in Bristol, found evidence of high levels of protection against hospitalisation in 80+ year olds with a single dose of either vaccine.</p>

<h4>SIREN study</h4>
<p>Early data from the <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00790-X/fulltext" rel="external" class="govuk-link">SIREN study</a> shows a promising impact on infection in healthcare workers aged under 65. Healthcare workers in the study are tested for COVID-19 every 2 weeks – whether or not they have symptoms.</p>

<h4>Early effectiveness of COVID-19 vaccines in older adults</h4>
<p><a href="https://www.bmj.com/content/373/bmj.n1088" class="govuk-link" rel="external">Early data from routine COVID-19 testing in older adults</a> shows that vaccines are effective at preventing COVID-19 disease and severe outcomes.</p>

<h4>Seroprevalence of SARS-CoV-2 among blood donors in England</h4>
<p>Report on the <a rel="external" href="https://khub.net/documents/135939561/390853656/Impact+of+COVID-19+vaccination+programme+on+seroprevalence+in+blood+donors+in+England.pdf/20d4b611-fda8-e70a-05eb-b13deb816ebf?t=1616002462349" class="govuk-link">impact of COVID-19 vaccination programme on seroprevalence in blood donors</a> in England, 2021.</p>

<p><a class="govuk-link" href="https://www.gov.uk/government/publications/phe-monitoring-of-the-effectiveness-of-covid-19-vaccination">Monitoring reports</a> published by Public Health England (now part of UKHSA),  <a class="govuk-link" href="https://www.gov.uk/government/publications/covid-19-vaccine-weekly-surveillance-reports">weekly COVID-19 surveillance reports</a> and <a class="govuk-link" href="https://www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2021-to-2022-season">weekly national flu and COVID-19 surveillance reports</a> are available.</p>

</div>

</div>

      <div class="responsive-bottom-margin">
        <div class="app-c-published-dates app-c-published-dates--history govuk-!-margin-bottom-3" data-module="gem-toggle" lang="en">
    Published 15 November 2021
    <br>Last updated 16 December 2021
      <a data-toggled-text="-&nbsp;hide all updates" href="#full-history" class="app-c-published-dates__toggle govuk-link" data-controls="full-history" data-expanded="false">+&nbsp;show all updates</a>
      <div class="app-c-published-dates__change-history js-hidden">
        <ol class="app-c-published-dates__list">
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-12-16T14:00:05.000+00:00" class="app-c-published-dates__change-date timestamp">16 December 2021</time>
              <p class="app-c-published-dates__change-note">Added effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against COVID-19 related symptoms and hospitalisation in England: test negative case-control study.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-12-10T16:52:05.000+00:00" class="app-c-published-dates__change-date timestamp">10 December 2021</time>
              <p class="app-c-published-dates__change-note">Added Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-11-15T09:35:00.000+00:00">15 November 2021</time>
              <p class="app-c-published-dates__change-note">First published.</p>
            </li>
        </ol>
      </div>
</div>


          
      </div>

  </div>
    
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
  </div>
  
<div class="govuk-grid-column-one-third">
  


</div>

</div>

  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav class="gem-c-related-navigation__nav-section" role="navigation" data-module="gem-toggle">

    <h2 class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul data-module="gem-track-click" class="gem-c-related-navigation__link-list">


        <li class="gem-c-related-navigation__link"><a data-track-options="{&quot;dimension28&quot;:&quot;3&quot;,&quot;dimension29&quot;:&quot;Immunisation&quot;}" data-track-action="1.1 Explore the topic" data-track-label="/health-and-social-care/health-protection-immunisation" class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" href="/health-and-social-care/health-protection-immunisation" data-track-category="relatedLinkClicked">Immunisation</a></li>
        <li class="gem-c-related-navigation__link"><a data-track-action="1.2 Explore the topic" data-track-options="{&quot;dimension28&quot;:&quot;3&quot;,&quot;dimension29&quot;:&quot;Infectious diseases&quot;}" href="/health-and-social-care/health-protection-infectious-diseases" data-track-label="/health-and-social-care/health-protection-infectious-diseases" class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-category="relatedLinkClicked">Infectious diseases</a></li>
        <li class="gem-c-related-navigation__link"><a data-track-category="relatedLinkClicked" data-track-label="/coronavirus-taxon/vaccinations" data-track-options="{&quot;dimension28&quot;:&quot;3&quot;,&quot;dimension29&quot;:&quot;Vaccinations for coronavirus&quot;}" href="/coronavirus-taxon/vaccinations" class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-action="1.3 Explore the topic">Vaccinations for coronavirus</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>